Lumiracoxib
- Generic Name
- Lumiracoxib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H13ClFNO2
- CAS Number
- 220991-20-8
- Unique Ingredient Identifier
- V91T9204HU
- Background
Lumiracoxib is a COX-2 selective non-steroidal anti-inflammatory drug (NSAID). On August 11, 2007, Australia's Therapeutic Goods Administration (TGA, the Australian equivalent of the FDA) cancelled the registration of lumiracoxib in Australia due to concerns that it may cause liver failure. New Zealand and Canada have also followed suit in recalling the drug.
- Indication
For the acute and chronic treatment of the signs and symptoms of osteoarthritis of the knee in adults.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath